| Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
|---|---|---|---|---|---|---|---|---|
| ENST00000263026 | eukaryotic elongation factor-2 kinase | protein coding | ENST00000438154 | 622 | 299 | UTR3 | Trans | |
| ENST00000263955 | serine/threonine kinase 17b | protein coding | ENST00000438154 | 585 | 299 | UTR3 | Trans | |
| ENST00000432564 | hydroxycarboxylic acid receptor 1 | protein coding | ENST00000438154 | 609 | 289 | UTR3 | Trans | |
| ENST00000494969 | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | protein coding | ENST00000438154 | 563 | 301 | CDS | Trans | |
| ENST00000572705 | transient receptor potential cation channel, subfamily V, member 1 | protein coding | ENST00000438154 | 629 | 283 | UTR3 | Trans | |
| TCONS_00027001 | programmed cell death 4 (neoplastic transformation inhibitor) | novel protein coding | ENST00000438154 | 622 | 285 | UTR3 | Trans | |
| TCONS_00027009 | programmed cell death 4 (neoplastic transformation inhibitor) | novel protein coding | ENST00000438154 | 622 | 285 | UTR3 | Trans | |
| TCONS_00030130 | calcium/calmodulin-dependent protein kinase II gamma | novel protein coding | ENST00000438154 | 679 | 283 | UTR3 | Trans | |
| TCONS_00067572 | DCN1, defective in cullin neddylation 1, domain containing 2 | novel protein coding | ENST00000438154 | 609 | 302 | UTR3 | Trans | |
| TCONS_00082423 | transcribed_processed_pseudogene | novel protein coding | ENST00000438154 | 533 | 284 | UTR3 | Trans | |
| TCONS_00089062 | eukaryotic elongation factor-2 kinase | novel protein coding | ENST00000438154 | 622 | 299 | UTR3 | Trans | |
| TCONS_00089065 | eukaryotic elongation factor-2 kinase | novel protein coding | ENST00000438154 | 622 | 299 | UTR3 | Trans | |
| TCONS_00089066 | eukaryotic elongation factor-2 kinase | novel protein coding | ENST00000438154 | 622 | 299 | UTR3 | Trans | |
| TCONS_00107851 | transient receptor potential cation channel, subfamily V, member 1 | novel protein coding | ENST00000438154 | 629 | 283 | UTR3 | Trans | |
| TCONS_00119512 | zinc finger and BTB domain containing 7C | novel protein coding | ENST00000438154 | 643 | 281 | UTR3 | Trans | |
| TCONS_00147093 | ATPase family, AAA domain containing 2B | novel protein coding | ENST00000438154 | 611 | 281 | UTR3 | Trans | |
| TCONS_00147100 | ATPase family, AAA domain containing 2B | novel protein coding | ENST00000438154 | 611 | 281 | UTR3 | Trans | |
| TCONS_00147106 | ATPase family, AAA domain containing 2B | novel protein coding | ENST00000438154 | 611 | 281 | UTR3 | Trans | |
| TCONS_00153158 | serine/threonine kinase 17b | novel protein coding | ENST00000438154 | 585 | 299 | UTR3 | Trans | |
| TCONS_00234854 | zinc finger and BTB domain containing 10 | novel protein coding | ENST00000438154 | 607 | 285 | UTR3 | Trans | |
| TCONS_00240688 | metastasis suppressor 1 | novel protein coding | ENST00000438154 | 602 | 285 | CDS_UTR | Trans |
>TCONS_00240688 (2325 nt)
TTTCTGCTGGCTGGATGGGGATGTGGAGGAGAGGACCCTTGGACCATGGGGATGGGAGCAACGTGCCAGGCATGGCAGCGCAATAGAGGGTGGAACATCT
TTTGAAGAGCTCAGACCCTGGACCCCTGATCTTAATGAGCTTTGCAGCCTTCAGTGACACAACCTGGATTTAAACTCATGGATGTCGGCCTCTGCTCTGC
GTTGAATTGTATCCTCCCAAAAAGGAGATGTTGGAGCTCTGAGACCCAGCACCTCAGAATGTGTTTCTACTTGGAAATAGGGTCTTTACCAAGACCCTAT
TCCAATAGGACTGGTGACCTGTGGGAGAAATGTGGACACAGAGACAGACAGACATAGAGGGAAGATGACGGCAGAGTCACAGGGAGAAGACGGTCATCTA
CGAGCCAAGGAGAGAGGCCTGGCACAGATCCTTCCCTCACAGCACCCAGAGAGCCTTCAGACAATACATCTGTGCTGTGTAAGCCGCTCCGTCTGTGGCT
CTCTGTTACAGCAGCCCCAGAAAACAAATAGAGACTCTTAATTGCCAAGCCATGTTCCTCCCATAGTACGATTTCTCATCAGATAGTCTATCTTCGCTGC
TAAAACAGGTATTTCTGGATGGTAGAGGTCATGTGTAGCTTGCATATTTAGTATGAGGTATGTGAAAGTCACCTCATAGATATTAAATTATTTGGCTACA
GCTTTGAGCTTGGCCTCTCTCTTAAGGATTACCTTGCCATAGGGACAGGAAGCCATCGTGATATAAAGGCTGAAGTTTCTGTAAGATTTTGATTTTTAAT
CTAACATGATATTAACAACTGTGCCCGTTGGGCGTGATGGCTCACACCTACAATCCCAGCACTTTGGGAGGCCAAGGCGGAGGATCACTTGAGGTCAGGA
GTTTGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACCAAAAATACAAAAATTAGCCGGGCTTGGGGGTGCATGCCTGTAATCCCAGCTACTTG
GGAGGCGAAGGCAGGAGAATTGCTTGAACCCAGGAGGTGGAGGTTGCAGTGAGCCAAGACTGTACCACTGCGCTCCAGCCTCGGCAACAGAGTGAGACTC
TGTCTCAAAACAGACAAACAAACAAAATAATAACTGTACCTATACAAGGTCCCCAAGATAATTAAAAGGCTCACTTGAGCAGAGTAACTGAGGAGAGTCT
TTTGGGGTTCTTTGTTTTTTTTTTTTAGAGACAGTCTCACTCTGTCGCCCAGTCTAGAGTGCAGAGGCGCAATCTTGGCTCACTGCAACCTCCGCCTCCC
AGGTTCAAGAGATCCTCCTGCCTCGGCCTCTCAAAGTGCTGGGACTACAGGCACATGCCACCATGTCCGGCTGAGGAATGTTTAATAAAAGGGGTATTTA
CCAAGATATAAGCAAGGTATAGAGAAATCAGCAGGGTTGATGAAGCACCCCGGGGCTACCAACAACCAAAAGCCCTTCCCTCTCCAAGGCCTCCAAAGGC
AGCAGGAGGGAGTGGTTATCAGAAAATGGCAAGATCCATAGGAAAAAGGCCACCCCATGGGAGCTGTGGGTTTCAGTAGAGGGACACAGCCACTGCCAGA
CCATGGCCAGCCAGGGAGTTAATAGCCCAGCCCCACCTTGGCCCTCCCATCTCCCACTCCTCCTTATTGGCTGAACCCAGCAAGAAACCAGATGTCACAG
AACCAGGAGATGTGGTCCCCACTGCCCGGCCTCTTGGGCACAGAGGAGGGAAGAGAAAATGGAGAGTGGATCTGGAGGGGCAAATGAAGTATTAATATTC
TGTACACTCAGAATGTCCACAGAGTGAACACTGGCTTGCCGGCTGACCCCATTTCTTGAAAATCATCCTATCCCTGCAGGTTATTTATGTTGTTACCCTT
TTGCAAGAACCACATAAAATATTTTACATGCTTTTAAAACTCATAAATGTAATGAAGCCAAGATGTTTCAGCAAATGTGCTCAATGGGCAAATCCTTCCA
AAGATCTGCTCTCAGCTGACGTCAGGACAAAAGGCACATCTCACGACCTGCAGAGCGTCTGACGTTAAAGCCAATAAATTCATCCCCCTGACCCACATGG
CTTCCAGAATGTACAAGCTGTCAGTGGATCTTAAAAATGTATCTATTCCTTCATTCACTTCCTGCCGTTCGTCTCTTGCAAGTATTTACTGCTCTTTAAA
AACTGAACTCCACCAGCTGGAAATGCATTAGTGCAGGGAGATGGCTGTACTTTGTTCCGGCAGGAATTGTGCATGCAACTTCCAATCTGACTTTTCTGAG
ACATTAATAAAAACACATGCGTCCTG
In silico ORF/peptide predictions
Nothing found.
RiboTaper predictions from Ribo-Seq data (HEK293 cell line)
Nothing found.